Doctors prescribe Lialda to help people with active, mild to moderate ulcerative colitis (UC) achieve remission.
Remission is about more than symptom control
Relief of symptoms and healing of the colon lining by reducing inflammation are both considered goals of UC treatment, according to guidelines from the American Gastroenterological Association.
Lialda can help control the symptoms of an ulcerative colitis flare and can also begin healing the lining of the colon by reducing inflammation.
As with all medications, Lialda may not be effective for everyone. In clinical trials, people taking Lialda who achieved remission had:
- No rectal bleeding
- Significant decrease in trips to the bathroom
- Reduced inflammation in the lining of the colon
Once-daily convenience
Lialda is easy to fit into your schedule. Most other oral mesalamines need to be taken from 2 to 4 times a day. But with Lialda, you can get a full dose of medicine with as few as 2 pills taken once a day with a meal. That's because Lialda contains the most mesalamine per tablet.
That means you can take Lialda in the morning, head off to work, school, or wherever your plans take you, and leave your pills at home.
MMX® Technology
Once-daily Lialda with Multi Matrix System (MMX®) Technology is designed to distribute mesalamine to and throughout the entire colon, where it’s needed most.
The Lialda tablet has an outer coating that delays the release of the medication until the tablet approaches the colon. Lialda is designed to dissolve slowly, forming a gel as it travels through the colon, prolonging the release of mesalamine throughout the site of ulcerative colitis inflammation.
